Growth Metrics

Boston Scientific (BSX) Accounts Payables (2016 - 2026)

Boston Scientific's Accounts Payables history spans 18 years, with the latest figure at $1.1 billion for Q1 2026.

  • On a quarterly basis, Accounts Payables rose 13.65% to $1.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 billion, a 13.65% increase, with the full-year FY2025 number at $1.1 billion, up 19.17% from a year prior.
  • Accounts Payables hit $1.1 billion in Q1 2026 for Boston Scientific, roughly flat from $1.1 billion in the prior quarter.
  • Over the last five years, Accounts Payables for BSX hit a ceiling of $1.1 billion in Q4 2025 and a floor of $696.0 million in Q1 2022.
  • Historically, Accounts Payables has averaged $922.2 million across 5 years, with a median of $921.0 million in 2024.
  • Biggest five-year swings in Accounts Payables: increased 24.71% in 2023 and later decreased 2.37% in 2024.
  • Tracing BSX's Accounts Payables over 5 years: stood at $862.0 million in 2022, then rose by 9.28% to $942.0 million in 2023, then rose by 1.91% to $960.0 million in 2024, then rose by 19.17% to $1.1 billion in 2025, then decreased by 0.26% to $1.1 billion in 2026.
  • Business Quant data shows Accounts Payables for BSX at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.0 billion in Q3 2025.